India’s Non-Communicable Diseases (NCD) screening programme, facilitated by Tata Trusts and Dell, has attracted the attention of several South Asian countries. Bangladesh, Bhutan, and Myanmar have already evinced interest in replicating the programme. This followed the World Health Organisation (WHO) presenting the programme to the 11

Till now no “major report of discordant test results” has been reported by COVID-19 testing laboratories, Minister of State for Health Ashwini Choubey told Rajya Sabha on Monday. He was responding to a question on whether capping the price of COVID-19 tests has forced several labs

India has been at the forefront in fighting the coronavirus pandemic and “really stands out” in terms of its vaccine policy, Chief Economist of the IMF Gita Gopinath said on Monday, as she hailed the country for playing a very important role during the crisis

The COVID-19 vaccine from Pfizer Inc and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday. Blood taken from people who had been given

A woman with a voice is by definition a strong woman. But the search to find that voice can be remarkably difficult.” –Melinda Gates. In Medgate's quest for the best , spanned over many years ,we have come across remarkable voices of healthcare. These brilliant women

A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the COVAXIN vaccine made by the Indian pharmaceutical company Bharat Biotech. The report by the committee for new molecules will be sent to the federal medical safety commission’s approval board,

The production of coronavirus vaccines and scaling up global availability could be seriously limited due to ban on exports of critical raw materials by the US, according to Serum Institute of India (SII) CEO Adar Poonawalla. He also called for regulatory harmonisation between organisations such as

Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, on Friday announced the first interim analysis of its BBV152 (COVAXIN®). The whole virion inactivated COVID-19 vaccine candidate demonstrated an interim vaccine efficacy of 81% in its Phase 3 clinical trial. The

Honeywell Automation India Limited (HAIL NSE: HONAUT) today announced Dr. Ganesh Natarajan’s appointment as Independent Director (Non-Executive) and Chairman of its Board of Directors, effective March 8, 2021. As Chairman of Board of Directors, Dr. Natarajan will offer guidance to HAIL’s management team on the company’s overall strategy,

Modified vaccines to protect against new variants of coronavirus can be fast-tracked through the approval system, the UK’s independent medicines regulator said on Thursday. The Medicines and Healthcare products Regulatory Agency (MHRA) said this is because authorised COVID-19 vaccines that are modified in response to new